Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

Data highlights ability of the Nodify XL2 test to identify benign nodules in patients with emphysema

...

Related Keywords

California ,United States ,San Diego ,American ,Arthur Romero ,International Conference ,American Thoracic Society ,University Of Nevada Las Vegas ,Nasdaq ,Oracle ,Biodesix Inc ,Thoracic Society ,Associate Professor ,Critical Care Medicine ,Nevada Las ,Nodify Lung ,Nodule Risk Assessment ,Private Securities Litigation Reform Act ,Risk Factors ,